Skip to content
Trial Eligibility
Menu

Lung Cancer Clinical Trials near Seattle, WA

98 studies for Lung Cancer are recruiting at 167 sites within 50 miles of Seattle, Washington, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Lung Cancer trials in the US or all trials near Seattle.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Lung Cancer studies enrolling near Seattle

Showing the 50 nearest of 98 studies.
  1. Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

    NCT03851445

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: FHCC at Northwest Hospital (Seattle, WA); Fred Hutchinson Cancer Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    13 sites within 50 mi
  2. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    NCT05334069

    • Observational
    • Ages 40 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest sites: Swedish Medical Center-Ballard Campus (Seattle, WA); Swedish Medical Center-Cherry Hill (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    9 sites within 50 mi
  3. A Study of Sigvotatug Vedotin in Advanced Solid Tumors

    NCT04389632

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Swedish Cancer Institute (Seattle, WA); Swedish Medical Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  4. Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

    NCT05642572

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: FHCC at Northwest Hospital (Seattle, WA); Fred Hutchinson Cancer Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  5. Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

    NCT06418204

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Kaiser Permanente Washington (Seattle, WA); Swedish Medical Center-First Hill (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  6. Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

    NCT06031688

    • Phase 2
    • Ages 18 Minutes and older
    • Sex: All

    Nearest sites: Swedish Medical Center-First Hill (Seattle, WA); Swedish Cancer Institute-Edmonds (Edmonds, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  7. Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

    NCT06096844

    • Phase 3
    • Ages 70 years and older
    • Sex: All

    Nearest sites: Swedish Medical Center-First Hill (Seattle, WA); Swedish Cancer Institute-Edmonds (Edmonds, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  8. Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

    NCT06116682

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Swedish Medical Center-First Hill (Seattle, WA); Swedish Cancer Institute-Edmonds (Edmonds, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  9. A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

    NCT06119581

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Swedish Medical Center (Seattle, WA); VA Puget Sound Health Care System (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  10. Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

    NCT06498635

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Swedish Medical Center-First Hill (Seattle, WA); Swedish Cancer Institute-Edmonds (Edmonds, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  11. A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

    NCT06627647

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Research Site (Seattle, WA); Research Site (Silverdale, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  12. A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

    NCT06692738

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Research Site (Seattle, WA); Research Site (Tacoma, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  13. Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

    NCT03191149

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Fred Hutchinson Cancer Center (Seattle, WA); University of Washington Medical Center - Montlake (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  14. Study of PF-07248144 in Advanced or Metastatic Solid Tumors

    NCT04606446

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Swedish Cancer Institute (Seattle, WA); Swedish Medical Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  15. Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

    NCT05061550

    • Phase 2
    • Ages 18 to 95 years
    • Sex: All

    Nearest sites: Research Site (Seattle, WA); Research Site (Edmonds, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  16. A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies

    NCT05443126

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: University of Washington - Fred Hutchinson Cancer Center (Seattle, WA); Washington University - School of Medicine (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  17. A Study of the Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung Cancer

    NCT06046495

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Research Site (Seattle, WA); Swedish Health Sciences (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  18. Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

    NCT06343402

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Fred Hutchinson Cancer Center (Seattle, WA); Northwest Medical Specialties (Tacoma, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  19. A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

    NCT06623422

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Swedish Cancer Institute ( Site 0143) (Seattle, WA); St. Joseph Medical Center Hematology and Oncology - Silverdale ( Site 0192) (Silverdale, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  20. A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

    NCT06646276

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Swedish Medical Center (Seattle, WA); Swedish Cancer Institute - Edmonds (Edmonds, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  21. Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

    NCT06890598

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Swedish Medical Center (Seattle, WA); Swedish Cancer Institute - Edmonds (Edmonds, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  22. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    NCT03452774

    • Observational
    • Ages Any age
    • Sex: All

    Nearest site: Massive Bio SYNERGY-AI site (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  23. PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer

    NCT04151940

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest site: Fred Hutch/University of Washington Cancer Consortium (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  24. Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers

    NCT04410796

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Washington (Data Collection Only) (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

    NCT04585750

    • Phase 1/2
    • Ages 12 years and older
    • Sex: All

    Nearest site: University of Washington, Fred Hutchinson Cancer Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  26. Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

    NCT04614103

    • Phase 2
    • Ages 18 to 70 years
    • Sex: All

    Nearest site: Seattle Cancer Care Alliance (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  27. Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

    NCT04981119

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: Fred Hutchinson Cancer Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  28. Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer

    NCT05098210

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Fred Hutch/University of Washington Cancer Consortium (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  29. A Study of NX-1607 in Adults With Advanced Malignancies

    NCT05107674

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Fred Hutchinson Cancer Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  30. Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

    NCT05379985

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Virginia Mason Medical Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  31. Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

    NCT05433142

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Xencor Investigative Site (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  32. A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

    NCT05498428

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Swedish Cancer Institute (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  33. SX-682 With Pembrolizumab for the Treatment of Metastatic or Recurrent Stage IIIC or IV Non-Small Cell Lung Cancer

    NCT05570825

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Fred Hutch/University of Washington Cancer Consortium (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  34. Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

    NCT05624996

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Virginia Mason Medical Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  35. A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

    NCT05652686

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Fred Hutch Cancer Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  36. Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

    NCT05786924

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Fred Hutchinson Cancer Research Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  37. Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

    NCT05983432

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Washington Fred Hutchinson (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  38. A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

    NCT06051695

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Fred Hutchinson Cancer Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  39. Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

    NCT06162221

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Fred Hutchinson Cancer Research Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  40. A Phase 1/1b Study of IAM1363 in HER2 Cancers

    NCT06253871

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Fred Hutchinson Cancer Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  41. A Study of KK2269 in Adult Participants With Solid Tumors

    NCT06266299

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Washington (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  42. A Study of IBI363 in Subjects with Advanced Solid Malignancies

    NCT06281678

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Fred Hutchinson Cancer Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  43. Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer

    NCT06518057

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Fred Hutch/University of Washington Cancer Consortium (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  44. SMP-3124LP in Adults With Advanced Solid Tumors

    NCT06526819

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Washington (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  45. Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

    NCT06562192

    • Phase 1
    • Ages 18 to 100 years
    • Sex: All

    Nearest site: University Of Washington (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  46. MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

    NCT06586515

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Fred Hutchinson Cancer Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  47. Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)

    NCT06598306

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Swedish Cancer Institute (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  48. A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

    NCT06618287

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Swedish Medical Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  49. Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

    NCT06625775

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Fred Hutchinson Cancer Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  50. First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

    NCT06657222

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Fred Hutchinson Cancer Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Lung Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.